Abstract
This study explores how glimepiride, alone or in combination with sitagliptin, affected glycemic control inType 2 diabetes patients. Type 2 diabetes was induced in rats by feeding them a high-fat diet and injectingthem with Alloxan and nicotinamide. Forty-two rats were divided equally into seven groups. Negativecontrol and group 2-7: rats fed with the HFD Positive control (diabetic non-treated) Group (T1, T2, T3, T4and T5) were treated with monotherapy and combination. All the treatment regimen reduces fasting bloodglucose and enhanced GLP-1 and insulin level as indicated by an increase in the area under the curve.Additionally, as opposed to monotherapies, the combination category had better glycemic regulation. As aresult, we assume that sitagliptin/glimepiride combined therapy has a synergistic effect.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Forensic Medicine & Toxicology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
